Repeated use of a substance leading to clinically significant impairment within a 12‑month period
Substance Use Disorder
Sedation & Decreased anxiety
Intended effects of Sedatives/Hypnotics/Anxiolytics
Begins 4–12 hours after last intake; lasts 5–7 days.
Withdrawal
Reverses respiratory depression Short half‑life → may require repeat dosing.
Naloxone
Body adapts to a substance and experiences physical withdrawal symptoms if it is stopped abruptly.
Dependence
Drowsiness, Agitation, Slurred speech, Nystagmus, Disorientation, N/V, Respiratory depression, Decreased LOC
Intoxication on Sedatives/Hypnotics/Anxiolytics
Occurs 2–3 days after cessationo. Medical emergency.
Delirium Tremens (DTs)
Full opioid agonist. Prevents withdrawal. Long‑term maintenance therapy.
Methadone
Compulsive use of a substance or engagement in a behavior despite harmful consequences and a lack of control.
Addiction
benzodiazepines, barbiturates
Examples of Sedatives/Hypnotics/ Anxiolytics
Tool used to assess severity of symptoms and guide medication dosing during withdrawal.
CIWA or CIWA-Ar
Partial agonist. Reduces cravings. Lower OD risk. For withdrawal and maintenance. Must be started in mild withdrawal.
Buprenorphine (Suboxone)
Experiencing physical and mental symptoms after stopping a habit-forming substance
Withdrawal
Antidote for benzodiazepine toxicity/overdose
Flumazenil
Reduce withdrawal severity and prevent seizures.
Benzodiazepines
Medicine approved to treat AUD and opioid use disorder by blocking opioid receptors in the brain.
Naltrexone